XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Previously Reported [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Previously Reported [Member]
AOCI Attributable to Parent [Member]
Previously Reported [Member]
Total
Beginning balance at Dec. 31, 2021   $ 6 $ 6 $ 5,604 $ (6) $ 5,598 $ (94,293) $ (94,293) $ 367 $ 367 $ (88,322) $ (88,322)
Beginning balance (in shares) at Dec. 31, 2021 10,474,509 51,668,426 62,142,935                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization upon Business Combination     $ 21     269,920           269,941
Conversion of redeemable convertible preferred stock to common stock in connection with reverse recapitalization upon Business Combination (in shares)     213,960,286                  
Business Combination and PIPE Financing, net of redemptions and transaction costs     $ 7     234,514           234,521
Business Combination and PIPE Financing, net of redemptions and transaction costs (in shares)     71,767,824                  
Forfeitures of Earn-Out restricted shares     (9,080)                  
Issuance of common stock upon exercise of stock options           4           4
Issuance of common stock upon exercise of stock options (in shares)     31,217                  
Stock-based compensation           3,186           3,186
Net Income (Loss)               (27,033)       (27,033)
Foreign currency translation adjustments                   109   109
Ending balance at Mar. 31, 2022     $ 34     513,222   (121,326)   476   392,406
Ending balance (in shares) at Mar. 31, 2022     347,893,182                  
Beginning balance at Dec. 31, 2021   $ 6 $ 6 $ 5,604 $ (6) 5,598 $ (94,293) (94,293) $ 367 367 $ (88,322) (88,322)
Beginning balance (in shares) at Dec. 31, 2021 10,474,509 51,668,426 62,142,935                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net Income (Loss)                       (18,018)
Foreign currency translation adjustments                       (1,268)
Ending balance at Jun. 30, 2022     $ 34     524,981   (112,311)   (901)   411,803
Ending balance (in shares) at Jun. 30, 2022     348,230,635                  
Beginning balance at Mar. 31, 2022     $ 34     513,222   (121,326)   476   392,406
Beginning balance (in shares) at Mar. 31, 2022     347,893,182                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Release of accrued transaction costs related to Business Combination and PIPE Financing           6,174           6,174
Issuance of common stock upon exercise of stock options           38           38
Issuance of common stock upon exercise of stock options (in shares)     337,453                  
Stock-based compensation           5,547           5,547
Net Income (Loss)               9,015       9,015
Foreign currency translation adjustments                   (1,377)   (1,377)
Ending balance at Jun. 30, 2022     $ 34     524,981   (112,311)   (901)   411,803
Ending balance (in shares) at Jun. 30, 2022     348,230,635                  
Beginning balance at Dec. 31, 2022     $ 35     538,041   (145,286)   (1,251)   391,539
Beginning balance (in shares) at Dec. 31, 2022     349,714,840                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Forfeitures of Earn-Out restricted shares     (1,904)                  
Issuance of common stock upon exercise of stock options           13           13
Issuance of common stock upon exercise of stock options (in shares)     94,319                  
Stock-based compensation           6,462           6,462
Restricted stock units vested (in shares)     4,727                  
Net Income (Loss)               (16,226)       (16,226)
Unrealized loss on investments                   467   467
Foreign currency translation adjustments                   72   72
Ending balance at Mar. 31, 2023     $ 35     544,516   (161,512)   (712)   382,327
Ending balance (in shares) at Mar. 31, 2023     349,811,982                  
Beginning balance at Dec. 31, 2022     $ 35     538,041   (145,286)   (1,251)   391,539
Beginning balance (in shares) at Dec. 31, 2022     349,714,840                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net Income (Loss)                       (29,174)
Unrealized loss on investments                       (254)
Foreign currency translation adjustments                       (1,420)
Ending balance at Jun. 30, 2023     $ 35     551,905   (174,460)   (2,925)   374,555
Ending balance (in shares) at Jun. 30, 2023     351,211,936                  
Beginning balance at Mar. 31, 2023     $ 35     544,516   (161,512)   (712)   382,327
Beginning balance (in shares) at Mar. 31, 2023     349,811,982                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Forfeitures of Earn-Out restricted shares     (237)                  
Issuance of common stock upon exercise of stock options           64           64
Issuance of common stock upon exercise of stock options (in shares)     477,443                  
Stock-based compensation           7,325           7,325
Restricted stock units vested (in shares)     924,179                  
Forfeitures of Restricted Stock Awards (in shares)     (1,431)                  
Net Income (Loss)               (12,948)       (12,948)
Unrealized loss on investments                   (721)   (721)
Foreign currency translation adjustments                   (1,492)   (1,492)
Ending balance at Jun. 30, 2023     $ 35     $ 551,905   $ (174,460)   $ (2,925)   $ 374,555
Ending balance (in shares) at Jun. 30, 2023     351,211,936